Cargando…

Human CD34(+) CD133(+) Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ(−/−) (NSG) Mice

Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications necessitates expansion of HSCs in vitro. Before these cells can be used they must be carefully evaluated to assess their stem cell activity. Here, we expanded cord blood CD34(+) CD133(+) cells in a defi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drake, Adam C., Khoury, Maroun, Leskov, Ilya, Iliopoulou, Bettina P., Fragoso, Maria, Lodish, Harvey, Chen, Jianzhu
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084708/ https://www.ncbi.nlm.nih.gov/pubmed/21559522 http://dx.doi.org/10.1371/journal.pone.0018382

Ejemplares similares

Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34(+) Cells in Immunodeficient NSG Mice
por: Svalgaard, Jesper Dyrendom, et al.
Publicado: (2018)

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice
por: Wiekmeijer, Anna-Sophia, et al.
Publicado: (2014)

Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34(+) cells
por: Kang, Young Kyung, et al.
Publicado: (2016)

Transplantation of human umbilical cord blood CD34(+) cells into the liver of newborn NOD/SCID/IL-2Rγ null (NSG) mice after busulfan conditioning
por: Ko, Yunmi, et al.
Publicado: (2017)

Expansion of Cord Blood CD34(+) Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse
por: M, Sangeetha V., et al.
Publicado: (2010)

Co-transplantation of Human Mesenchymal Stem Cells Promotes Human CD34+ Cells Engraftment in a Dose-dependent Fashion in NOD/SCID Mice
por: Park, Seong-Kyu, et al.
Publicado: (2007)

Correction: Expansion of Cord Blood CD34(+) Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse
Publicado: (2014)

Spiny mice (Acomys) cells fail to engraft in NOD scid gamma
por: Gaire, Janak, et al.
Publicado: (2023)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016)

Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice
por: Walcher, Lia, et al.
Publicado: (2018)

The Preconditioning of Busulfan Promotes Efficiency of Human CD133+ Cells Engraftment in NOD Shi-SCID IL2Rγcnull (NOG) Mice via Intra-Bone Marrow Injection
por: Guo, Xiaofang, et al.
Publicado: (2019)

Higher susceptibility of NOD/LtSz-scid Il2rg(−/−) NSG mice to xenotransplanted lung cancer cell lines
por: Kanaji, Nobuhiro, et al.
Publicado: (2014)

Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling
por: Queudeville, M, et al.
Publicado: (2012)

A radiolabeled antibody targeting CD123(+) leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML
por: Leyton, Jeffrey V., et al.
Publicado: (2015)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Failure of Effector Function of Human CD8(+) T Cells in NOD/SCID/JAK3(−/−) Immunodeficient Mice Transplanted with Human CD34(+) Hematopoietic Stem Cells
por: Sato, Yoshinori, et al.
Publicado: (2010)

Characteristics of human primary mantle cell lymphoma engraftment in NSG mice
por: Iyengar, Sunil, et al.
Publicado: (2015)

Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice
por: Futrega, Kathryn, et al.
Publicado: (2016)

Human Umbilical Cord Blood-Derived CD34(+) Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities
por: Aggarwal, Reeva, et al.
Publicado: (2012)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

Nanofiber-expanded human umbilical cord blood–derived CD34(+) cell therapy accelerates cutaneous wound closure in NOD/SCID mice
por: Kanji, Suman, et al.
Publicado: (2014)

Busulfan Administration Flexibility Increases the Applicability of Scid Repopulating Cell Assay in NSG Mouse Model
por: Chevaleyre, Jean, et al.
Publicado: (2013)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

CD34+CD146+ adipose‐derived stromal cells enhance engraftment of transplanted fat
por: Borrelli, Mimi R., et al.
Publicado: (2020)

Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
por: Flavell, D J, et al.
Publicado: (2000)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Correction: Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
por: Kim, Sung-Whan, et al.
Publicado: (2012)

Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells
Publicado: (1991)

CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
por: Van der Meer, Jolien M.R., et al.
Publicado: (2021)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice
por: ZUNINO, SUSAN J., et al.
Publicado: (2012)

Long-Term Quantitative Biodistribution and Side Effects of Human Mesenchymal Stem Cells (hMSCs) Engraftment in NOD/SCID Mice following Irradiation
por: François, Sabine, et al.
Publicado: (2014)

Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34(+) Hematopoietic Progenitor Cells and Humanized NSG Mice
por: Crawford, Lindsey B., et al.
Publicado: (2019)

Genomic and Proteomic Analysis of the Impact of Mitotic Quiescence on the Engraftment of Human CD34(+) Cells
por: Chitteti, Brahmananda Reddy, et al.
Publicado: (2011)

Human Cytomegalovirus Infection Suppresses CD34(+) Progenitor Cell Engraftment in Humanized Mice
por: Crawford, Lindsey B., et al.
Publicado: (2020)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

Umbilical cord blood CD34(+) progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg(null) mice
por: Hoogstad-van Evert, Janneke S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_adaimoula8o7stbfbimss4enbl